scispace - formally typeset
J

Julien Sage

Researcher at Stanford University

Publications -  192
Citations -  19617

Julien Sage is an academic researcher from Stanford University. The author has contributed to research in topics: Cancer & Cell cycle. The author has an hindex of 63, co-authored 169 publications receiving 15340 citations. Previous affiliations of Julien Sage include University of California, Davis & Massachusetts Institute of Technology.

Papers
More filters
Journal ArticleDOI

Comprehensive genomic profiles of small cell lung cancer

Julie George, +95 more
- 06 Aug 2015 - 
TL;DR: This first comprehensive study of somatic genome alterations in SCLC uncovers several key biological processes and identifies candidate therapeutic targets in this highly lethal form of cancer.
Journal ArticleDOI

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

Martin Peifer, +94 more
- 01 Oct 2012 - 
TL;DR: This study implicates histone modification as a major feature of SCLC, reveals potentially therapeutically tractable genomic alterations and provides a generalizable framework for the identification of biologically relevant genes in the context of high mutational background.
Journal ArticleDOI

Cellular mechanisms of tumour suppression by the retinoblastoma gene

TL;DR: The retinoblastoma (RB) tumour suppressor gene is functionally inactivated in a broad range of paediatric and adult cancers, and a plethora of cellular functions and partners have been identified for the RB protein.
Journal ArticleDOI

Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data

TL;DR: A systematic computational approach to predict novel therapeutic indications on the basis of comprehensive testing of molecular signatures in drug-disease pairs for repositioning established drugs to treat a wide range of human diseases.
Journal ArticleDOI

Targeted disruption of the three Rb-related genes leads to loss of G1 control and immortalization

TL;DR: The results confirm the essential role of the Rb family in the control of the G(1)/S transition, place the three R b family members downstream of multiple cell cycle control pathways, and further the link between loss of cell cycle Control and tumorigenesis.